Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

May 27, 2014; 82 (21) Article

Effects of cannabis on cognition in patients with MS

A psychometric and MRI study

Bennis Pavisian, Bradley J. MacIntosh, Greg Szilagyi, Richard W. Staines, Paul O'Connor, Anthony Feinstein
First published April 30, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000446
Bennis Pavisian
From the Sunnybrook Research Institute (B.P., B.J.M., G.S., A.F.) and St. Michael's Hospital (P.O.), University of Toronto (P.O., A.F.); and Department of Kinesiology (R.W.S.), University of Waterloo, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley J. MacIntosh
From the Sunnybrook Research Institute (B.P., B.J.M., G.S., A.F.) and St. Michael's Hospital (P.O.), University of Toronto (P.O., A.F.); and Department of Kinesiology (R.W.S.), University of Waterloo, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg Szilagyi
From the Sunnybrook Research Institute (B.P., B.J.M., G.S., A.F.) and St. Michael's Hospital (P.O.), University of Toronto (P.O., A.F.); and Department of Kinesiology (R.W.S.), University of Waterloo, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard W. Staines
From the Sunnybrook Research Institute (B.P., B.J.M., G.S., A.F.) and St. Michael's Hospital (P.O.), University of Toronto (P.O., A.F.); and Department of Kinesiology (R.W.S.), University of Waterloo, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul O'Connor
From the Sunnybrook Research Institute (B.P., B.J.M., G.S., A.F.) and St. Michael's Hospital (P.O.), University of Toronto (P.O., A.F.); and Department of Kinesiology (R.W.S.), University of Waterloo, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Feinstein
From the Sunnybrook Research Institute (B.P., B.J.M., G.S., A.F.) and St. Michael's Hospital (P.O.), University of Toronto (P.O., A.F.); and Department of Kinesiology (R.W.S.), University of Waterloo, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Effects of cannabis on cognition in patients with MS
A psychometric and MRI study
Bennis Pavisian, Bradley J. MacIntosh, Greg Szilagyi, Richard W. Staines, Paul O'Connor, Anthony Feinstein
Neurology May 2014, 82 (21) 1879-1887; DOI: 10.1212/WNL.0000000000000446

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1410

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objective: To determine functional and structural neuroimaging correlates of cognitive dysfunction associated with cannabis use in multiple sclerosis (MS).

Methods: In a cross-sectional study, 20 subjects with MS who smoked cannabis and 19 noncannabis users with MS, matched on demographic and neurologic variables, underwent fMRI while completing a test of working memory, the N-Back. Resting-state fMRI and structural MRI data (lesion and normal-appearing brain tissue volumes, diffusion tensor imaging metrics) were also collected. Neuropsychological data pertaining to verbal (Selective Reminding Test Revised) and visual (10/36 Spatial Recall Test) memory, information processing speed (Paced Auditory Serial Addition Test [2- and 3-second versions] and Symbol Digit Modalities Test), and attention (Word List Generation) were obtained.

Results: The cannabis group performed more poorly on the more demanding of the Paced Auditory Serial Addition Test tasks (i.e., 2-second version) (p < 0.02) and the 10/36 Spatial Recall Test (p < 0.03). Cannabis users had more diffuse cerebral activation across all N-Back trials and made more errors on the 2-Back task (p < 0.006), during which they displayed increased activation relative to nonusers in parietal (p < 0.007) and anterior cingulate (p < 0.001) regions implicated in working memory. No group differences in resting-state networks or structural MRI variables were found.

Conclusions: Patients with MS who smoke cannabis are more cognitively impaired than nonusers. Cannabis further compromises cerebral compensatory mechanisms, already faulty in MS. These imaging data boost the construct validity of the neuropsychological findings and act as a cautionary note to cannabis users and prescribers.

GLOSSARY

DTI=
diffusion tensor imaging;
FA=
fractional anisotropy;
FOV=
field of view;
MD=
mean diffusivity;
MNI=
Montreal Neurological Institute;
MS=
multiple sclerosis;
NAGM=
normal-appearing gray matter;
NAWM=
normal-appearing white matter;
RSN=
resting-state network;
TE=
echo time;
TR=
repetition time;
PASAT=
Paced Auditory Serial Addition Test

Footnotes

  • Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Supplemental data at Neurology.org

  • Received July 5, 2013.
  • Accepted in final form February 24, 2014.
  • © 2014 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • GLOSSARY
    • METHODS
    • RESULTS
    • DISCUSSION
    • AUTHOR CONTRIBUTIONS
    • STUDY FUNDING
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Topics Discussed

  • All Neuropsychology/Behavior
  • Multiple sclerosis
  • MRI
  • fMRI

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Effects of cannabis on cognitive function in patients with multiple sclerosis
    Kimia Honarmand, Mary C. Tierney, Paul O'Connor et al.
    Neurology, March 28, 2011
  • Articles
    Multiple sclerosis and cannabis
    A cognitive and psychiatric study
    Omar Ghaffar, Anthony Feinstein et al.
    Neurology, February 13, 2008
  • Articles
    Default-mode network dysfunction and cognitive impairment in progressive MS
    M.A. Rocca, P. Valsasina, M. Absinta et al.
    Neurology, April 19, 2010
  • Articles
    White matter integrity related to functional working memory networks in traumatic brain injury
    E.M. Palacios, R. Sala-Llonch, C. Junque et al.
    Neurology, February 15, 2012
Neurology: 100 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise